Successful treatment with subcutaneous ofatumumab in an adolescent patient with refractory myelin oligodendrocyte glycoprotein-immunoglobulin G-associated disease (MOGAD)

Preventing relapse of myelin oligodendrocyte glycoprotein-immunoglobulin G-associated disease (MOGAD) with steroids and immunosuppressants is sometimes difficult. There is no standard treatment for refractory cases. We present the case of a 17-year-old female patient with longitudinally extensive my...

Descripción completa

Detalles Bibliográficos
Autores principales: Hiya, Satomi, Yoshimura, Hajime, Kawamoto, Michi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10139969/
https://www.ncbi.nlm.nih.gov/pubmed/37122491
http://dx.doi.org/10.1016/j.ensci.2023.100461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10139969/
https://www.ncbi.nlm.nih.gov/pubmed/37122491
http://dx.doi.org/10.1016/j.ensci.2023.100461

Ejemplares similares